Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody
- PMID: 1702163
- PMCID: PMC240544
- DOI: 10.1128/JVI.65.1.489-493.1991
Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody
Abstract
A human monoclonal antibody designated 15e is reactive with the envelope glycoprotein (gp120) of multiple isolates of human immunodeficiency virus type 1 (HIV-1). Antibody 15e also neutralizes HIV-1 with broad specificity and blocks gp120 binding to CD4. Characterization of the 15e epitope shows that it is conformation dependent and is distinct from previously recognized functional domains of gp120, suggesting that this epitope represents a novel site important for HIV-1 neutralization and CD4 binding. These findings have implications for the development of a vaccine for AIDS.
Similar articles
-
Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52. doi: 10.1073/pnas.88.20.8949. Proc Natl Acad Sci U S A. 1991. PMID: 1717992 Free PMC article.
-
Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994. J Virol. 1994. PMID: 7520095 Free PMC article.
-
Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.Virology. 1995 Aug 20;211(2):583-8. doi: 10.1006/viro.1995.1441. Virology. 1995. PMID: 7544051
-
Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.J Virol. 1993 Oct;67(10):6179-91. doi: 10.1128/JVI.67.10.6179-6191.1993. J Virol. 1993. PMID: 7690420 Free PMC article.
-
Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.J Gen Virol. 1996 Dec;77 ( Pt 12):2905-19. doi: 10.1099/0022-1317-77-12-2905. J Gen Virol. 1996. PMID: 9000081 Review. No abstract available.
Cited by
-
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.J Virol. 1992 Feb;66(2):848-56. doi: 10.1128/JVI.66.2.848-856.1992. J Virol. 1992. PMID: 1370558 Free PMC article.
-
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.J Virol. 1994 Jan;68(1):469-84. doi: 10.1128/JVI.68.1.469-484.1994. J Virol. 1994. PMID: 7504741 Free PMC article.
-
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.J Virol. 1995 Jan;69(1):222-30. doi: 10.1128/JVI.69.1.222-230.1995. J Virol. 1995. PMID: 7527084 Free PMC article.
-
Pathogenesis of human immunodeficiency virus infection.Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993. Microbiol Rev. 1993. PMID: 8464405 Free PMC article. Review.
-
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.J Virol. 1997 Dec;71(12):9808-12. doi: 10.1128/JVI.71.12.9808-9812.1997. J Virol. 1997. PMID: 9371651 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials